Israel's Together gets Canadian deal for five tonnes of cannabis oil

Israel’s Together has agreed to sell 5 tonnes of cannabis oil to an unnamed Canadian company that will potentially bring revenue of hundreds of millions of shekels.

The Canadian company will buy from Together subsidiary Globus Pharma 50 tonnes of dried inflorescences of cannabis each year, which is equivalent to five tonnes of medical cannabis oil.

The two companies will also collaborate in the field of research and development and promoting technologies in the medical cannabis sector. They have estimated sales will amount to $3.17 to $4.7 per gram of inflorescence.


This country could be close to exporting medical marijuana

Israel’s cabinet is set to legalize exports of medical marijuana on Sunday after Public Security Minister Gilad Erdan’s reservations about criminal use were assuaged by a promise for 25 more police officers to monitor growers.

“I support the use of marijuana for medical purposes and exporting it to the world in light of our [Israel’s] advanced knowledge in the field,” Erdan said in a statement on Wednesday. “But as public security minster I am obligated to make certain that exports from farms aren’t diverted to illicit use by Israeli citizens, especially the young.”

Under the proposed law, 50 growers will be given licenses to export marijuana solely for medical purposes and as a finished product, not in the form of seeds, stems or plants, sources said.


Israel’s global cannabis dominance will help the U.S.

Researchers here in the U.S. are eager to run trials with high quality Israeli cannabis strains they cannot get anywhere else.

The strongest, most influential medical cannabis economy in the world is not where most would think.

Cue Israel, which is an agricultural superpower already and has a great green thumb for cannabis cultivation.

Why? Mainly because Israel is leading the globe when it comes to legitimate cannabis research on medical applications for serious illnesses.


TASE investors get high on Israel's cannabis stocks

It is unclear whether medical cannabis exports will be permitted, but share prices of companies in the industry are soaring.

The medical cannabis market in Israel is undergoing a period of uncertainty. The big question now is whether exports of cannabis products from Israel will be allowed, and if so, when.

Despite the uncertainty in the sector, shares in cannabis companies have overtaken cryptocurrencies as the latest hot market shakers on the TASE.

Cannabis share prices soared by triple-digit percentages over the past week, and trading in them is currently very volatile. Is this a bubble? This will become known only at a later stage, but there is no doubt that the cannabis market is behaving like an investment fashion.


A convention of cannabis minds at the CannaTech conference

The CannaTech Conference was just held March 18-21, 2018, in Tel Aviv, Israel. The conference was about as comprehensive as a medical cannabis conference could be.

The most significant global industry leaders were there, and thought leaders led workshops in the fields of research and science, medicine, finance, technology innovation, agriculture and government policy--all with a singular focus on medical cannabis.

The event was an amazing showcase into the groundbreaking and very significant contributions in all of these fields.


Israeli medical marijuana grower to move farm abroad

Red tape stalls leading country’s green export potential.

Together Pharma, a recently-incorporated Israeli medical-marijuana firm, announced on Sunday that it would relocate part of its cultivation outside of the country, amid regulatory uncertainty over whether exports would eventually be permitted.

The government reportedly told medicinal marijuana companies that their cannabis exports would be approved by 2018, according to industry employees. That persuaded the companies to embark on multi-billion-shekel investments, many of which could now be in jeopardy.


Israel first country to approve medical cannabis vaporizer

The Israeli Ministry of Health has approved Kanabo Research’s medical cannabis vaporizer as a medical device.

Israel has become the first county in the world to grant medical device approval to a vaporizer for the use of medical cannabis extracts and formulations.

The Israeli Ministry of Health has granted initial approval as a medical device to the VapePod vaporizer developed by Kanabo Research, a Tel-Aviv-based medical cannabis R&D company.


Israel could soon decriminalize marijuana

With a vote on a new bill this week in the Knesset, Israel could soon decriminalize marijuana. The Knesset is Israel’s legislative body.

It voted unanimously to pass the bill on its first reading on March 7. Two more successful votes are required for the measure to become law.

The law changes penalties for those caught possessing cannabis in public. Fines would replace jail time for most offenses.

Public Security and Strategic Affairs Minister Gilad Erdan leads the effort to pass the bill.


Israel's parliament unanimously votes to progress cannabis decriminalization

'The law is far from perfect, but it's a foot in the door on the way to full legalisation'.

A bill to decriminalise cannabis use passed was unanimously in its first reading in Israel‘s parliament. 

The proposal would mean those caught smoking marijuana would be fined rather than arrested and prosecuted. 

First-time offenders would be fined 1,000 shekels (£209), second-time offenders fined double and those caught a third time would face a “probation” period. 

Only on the fourth offence could individuals be subject to criminal proceedings. 


Israeli medical cannabis company announces record $110 million deal

Medivie Therapeutic warns it will sell knowledge instead of plants if government fails to legalize exports soon.

An Israeli company on Sunday announced a $110 million deal to grow and produce medical cannabis for a European buyer in what it said was the biggest agreement of its kind to be signed in Israel to date.

But it threatened that if the Israeli government did not approve the export of medical cannabis soon, it would sell its knowledge and expertise rather than the cannabis itself.

Medivie Therapeutic and its subsidiary High Pharma will earmark around 100 dunams (25 acres) of land to grow, produce and export up to 50 tons of medical cannabis to the investor each year.


Subscribe to RSS - Israel